293 related articles for article (PubMed ID: 16968318)
1. Gaining insight into the what, why and where of complementary and alternative medicine use by cancer patients and survivors.
Humpel N; Jones SC
Eur J Cancer Care (Engl); 2006 Sep; 15(4):362-8. PubMed ID: 16968318
[TBL] [Abstract][Full Text] [Related]
2. Assessing the role of evidence in patients' evaluation of complementary therapies: a quality study.
Verhoef MJ; Mulkins A; Carlson LE; Hilsden RJ; Kania A
Integr Cancer Ther; 2007 Dec; 6(4):345-53. PubMed ID: 18048882
[TBL] [Abstract][Full Text] [Related]
3. Use of complementary and alternative medicine by cancer patients at the University of Nigeria Teaching Hospital, Enugu, Nigeria.
Ezeome ER; Anarado AN
BMC Complement Altern Med; 2007 Sep; 7():28. PubMed ID: 17850665
[TBL] [Abstract][Full Text] [Related]
4. Why some cancer patients choose complementary and alternative medicine instead of conventional treatment.
Shumay DM; Maskarinec G; Kakai H; Gotay CC;
J Fam Pract; 2001 Dec; 50(12):1067. PubMed ID: 11742609
[TBL] [Abstract][Full Text] [Related]
5. Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives.
Tasaki K; Maskarinec G; Shumay DM; Tatsumura Y; Kakai H
Psychooncology; 2002; 11(3):212-20. PubMed ID: 12112481
[TBL] [Abstract][Full Text] [Related]
6. The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre.
Chrystal K; Allan S; Forgeson G; Isaacs R
N Z Med J; 2003 Jan; 116(1168):U296. PubMed ID: 12601420
[TBL] [Abstract][Full Text] [Related]
7. Use of complementary and alternative medicine among cancer patients in Israel.
Pud D; Kaner E; Morag A; Ben-Ami S; Yaffe A
Eur J Oncol Nurs; 2005 Jun; 9(2):124-30. PubMed ID: 15944105
[TBL] [Abstract][Full Text] [Related]
8. Religious and spiritual resources, CAM, and conventional treatment in the lives of cancer patients.
Tatsumura Y; Maskarinec G; Shumay DM; Kakai H
Altern Ther Health Med; 2003; 9(3):64-71. PubMed ID: 12776477
[TBL] [Abstract][Full Text] [Related]
9. Disclosing complementary and alternative medicine use in the medical encounter: a qualitative study in women with breast cancer.
Adler SR; Fosket JR
J Fam Pract; 1999 Jun; 48(6):453-8. PubMed ID: 10386489
[TBL] [Abstract][Full Text] [Related]
10. Use of complementary and alternative medicine and prayer among a national sample of cancer survivors compared to other populations without cancer.
Mao JJ; Farrar JT; Xie SX; Bowman MA; Armstrong K
Complement Ther Med; 2007 Mar; 15(1):21-9. PubMed ID: 17352968
[TBL] [Abstract][Full Text] [Related]
11. The use of complementary and alternative therapies by cancer patients in northern Israel.
Hana G; Bar-Sela G; Zhana D; Mashiach T; Robinson E
Isr Med Assoc J; 2005 Apr; 7(4):243-7. PubMed ID: 15847205
[TBL] [Abstract][Full Text] [Related]
12. The use of complementary and alternative medicine by cancer patients undergoing radiation therapy.
Swarup AB; Barrett W; Jazieh AR
Am J Clin Oncol; 2006 Oct; 29(5):468-73. PubMed ID: 17023781
[TBL] [Abstract][Full Text] [Related]
13. Understanding the motivation for conventional and complementary/alternative medicine use among men with prostate cancer.
Singh H; Maskarinec G; Shumay DM
Integr Cancer Ther; 2005 Jun; 4(2):187-94. PubMed ID: 15911931
[TBL] [Abstract][Full Text] [Related]
14. Factors predicting the use of complementary and alternative therapies among cancer patients in Iran.
Montazeri A; Sajadian A; Ebrahimi M; Haghighat S; Harirchi I
Eur J Cancer Care (Engl); 2007 Mar; 16(2):144-9. PubMed ID: 17371423
[TBL] [Abstract][Full Text] [Related]
15. A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer.
Eng J; Ramsum D; Verhoef M; Guns E; Davison J; Gallagher R
Integr Cancer Ther; 2003 Sep; 2(3):212-6. PubMed ID: 15035882
[TBL] [Abstract][Full Text] [Related]
16. Empowering the cancer patient or controlling the tumor? A qualitative study of how cancer patients experience consultations with complementary and alternative medicine practitioners and physicians, respectively.
Steinsbekk A; Launsø L
Integr Cancer Ther; 2005 Jun; 4(2):195-200. PubMed ID: 15911932
[TBL] [Abstract][Full Text] [Related]
17. What is an exceptional cancer trajectory?: Multiple stakeholder perspectives on cancer trajectories in relation to complementary and alternative medicine use.
Hök J; Forss A; Falkenberg T; Tishelman C
Integr Cancer Ther; 2009 Jun; 8(2):153-63. PubMed ID: 19679624
[TBL] [Abstract][Full Text] [Related]
18. Communication in cancer care: discussing complementary and alternative medicine.
Frenkel M; Ben-Arye E; Cohen L
Integr Cancer Ther; 2010 Jun; 9(2):177-85. PubMed ID: 20356950
[TBL] [Abstract][Full Text] [Related]
19. The use of complementary and alternative (non-conventional) medicine in cancer patients in Turkey.
Algier LA; Hanoglu Z; Ozden G; Kara F
Eur J Oncol Nurs; 2005 Jun; 9(2):138-46. PubMed ID: 15899593
[TBL] [Abstract][Full Text] [Related]
20. Complementary medicine use among women enrolled in a genetic testing program.
DiGianni LM; Kim HT; Emmons K; Gelman R; Kalkbrenner KJ; Garber JE
Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):321-6. PubMed ID: 12692106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
